218 related articles for article (PubMed ID: 35093100)
1. Factors affecting optimal adherence to antiretroviral therapy and viral suppression amongst HIV-infected prisoners in South Ethiopia: a comparative cross-sectional study.
Fuge TG; Tsourtos G; Miller ER
AIDS Res Ther; 2022 Jan; 19(1):5. PubMed ID: 35093100
[TBL] [Abstract][Full Text] [Related]
2. Imprisonment for South Ethiopian people living with HIV presents a double health burden: lived experiences of prisoners.
Fuge TG; Tsourtos G; Miller ER
BMC Health Serv Res; 2024 Jan; 24(1):122. PubMed ID: 38254096
[TBL] [Abstract][Full Text] [Related]
3. Various structural factors influenced early antiretroviral therapy initiation amongst HIV infected prisoners: a qualitative exploration in South Ethiopia.
Fuge TG; Tsourtos G; Miller ER
BMC Public Health; 2021 Jul; 21(1):1463. PubMed ID: 34320958
[TBL] [Abstract][Full Text] [Related]
4. A systematic review and meta-analyses on initiation, adherence and outcomes of antiretroviral therapy in incarcerated people.
Fuge TG; Tsourtos G; Miller ER
PLoS One; 2020; 15(5):e0233355. PubMed ID: 32421754
[TBL] [Abstract][Full Text] [Related]
5. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
6. Barriers to optimal antiretroviral therapy adherence among HIV-infected formerly incarcerated individuals in New York City.
Rowell-Cunsolo TL; Hu G
PLoS One; 2020; 15(6):e0233842. PubMed ID: 32479552
[TBL] [Abstract][Full Text] [Related]
7. Sociodemographic factors affecting viral load suppression among people living with HIV in South Carolina.
Haider MR; Brown MJ; Harrison S; Yang X; Ingram L; Bhochhibhoya A; Hamilton A; Olatosi B; Li X
AIDS Care; 2021 Mar; 33(3):290-298. PubMed ID: 31856584
[TBL] [Abstract][Full Text] [Related]
8. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.
Meyer JP; Cepeda J; Wu J; Trestman RL; Altice FL; Springer SA
JAMA Intern Med; 2014 May; 174(5):721-9. PubMed ID: 24687044
[TBL] [Abstract][Full Text] [Related]
9. Retention in HIV care during the 3 years following release from incarceration: A cohort study.
Loeliger KB; Meyer JP; Desai MM; Ciarleglio MM; Gallagher C; Altice FL
PLoS Med; 2018 Oct; 15(10):e1002667. PubMed ID: 30300351
[TBL] [Abstract][Full Text] [Related]
10. Effects of incentivizing viral suppression in previously incarcerated adults living with HIV.
Toegel F; Holtyn AF; Pollock S; Rodewald AM; Leoutsakos JM; Fingerhood M; Silverman K
HIV Res Clin Pract; 2020 Feb; 21(1):1-10. PubMed ID: 32133931
[No Abstract] [Full Text] [Related]
11. HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study.
Desta AA; Woldearegay TW; Futwi N; Gebrehiwot GT; Gebru GG; Berhe AA; Godefay H
BMC Infect Dis; 2020 Jan; 20(1):4. PubMed ID: 31898535
[TBL] [Abstract][Full Text] [Related]
12. The association of recent incarceration and health outcomes among HIV-infected adults receiving care in the United States.
Nasrullah M; Frazier E; Fagan J; Hardnett F; Skarbinski J
Int J Prison Health; 2016 Sep; 12(3):135-44. PubMed ID: 27548016
[TBL] [Abstract][Full Text] [Related]
13. Level of Antiretroviral Therapy Adherence and Associated Factors Among People Living with HIV in the Context of Early Antiretroviral Therapy Initiation in Wolaita Sodo Town, Ethiopia: Cross-Sectional Study.
Haile Hantalo A; Tantu Arusi T; Kolato Koche S
AIDS Res Hum Retroviruses; 2023 Oct; 39(10):518-524. PubMed ID: 37243444
[TBL] [Abstract][Full Text] [Related]
14. Adherence to Antiretroviral Therapy and Associated Factors among People Living with HIV/AIDS in Hara Town and Its Surroundings, North-Eastern Ethiopia: A Cross-Sectional Study.
Legesse TA; Reta MA
Ethiop J Health Sci; 2019 May; 29(3):299-308. PubMed ID: 31447498
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral Adherence Following Prison Release in a Randomized Trial of the imPACT Intervention to Maintain Suppression of HIV Viremia.
DiPrete BL; Pence BW; Golin CE; Knight K; Flynn PM; Carda-Auten J; Groves JS; Powers KA; White BL; Napravnik S; Wohl DA
AIDS Behav; 2019 Sep; 23(9):2386-2395. PubMed ID: 30963321
[TBL] [Abstract][Full Text] [Related]
16. Acceptability and feasibility of short message service to improve ART medication adherence among people living with HIV/AIDS receiving antiretroviral treatment at Adama hospital medical college, Central Ethiopia.
Endebu T; Deksisa A; Dugasa W; Mulu E; Bogale T
BMC Public Health; 2019 Oct; 19(1):1315. PubMed ID: 31638936
[TBL] [Abstract][Full Text] [Related]
17. The predictors of unsuppressed viremia among PLHIV: a cross-sectional study in Ghana.
Owusu LB; Ababio C; Boahene S; Zakaria AS; Emikpe AO; Dwumfour CK; Appiagyei KA; Apiribu F
BMC Public Health; 2023 Jun; 23(1):1113. PubMed ID: 37296400
[TBL] [Abstract][Full Text] [Related]
18. Prisoners' access to HIV services in southern Malawi: a cross-sectional mixed methods study.
Gondwe A; Amberbir A; Singogo E; Berman J; Singano V; Theu J; Gaven S; Mwapasa V; Hosseinipour MC; Paul M; Chiwaula L; van Oosterhout JJ
BMC Public Health; 2021 Apr; 21(1):813. PubMed ID: 33910547
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting adherence to antiretroviral therapy among children and adolescents living with HIV in the Mbita Sub-County Hospital, Homa Bay- Kenya.
Tanyi WN; Gachuno O; Odero T; Farquhar C; Kimosop D; Mayi A
Afr Health Sci; 2021 May; 21(Suppl):18-24. PubMed ID: 34447419
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and factors associated with HIV treatment non-adherence among people living with HIV in three regions of Cameroon: A cross-sectional study.
Buh A; Deonandan R; Gomes J; Krentel A; Oladimeji O; Yaya S
PLoS One; 2023; 18(4):e0283991. PubMed ID: 37014900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
